RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-72.12M -39.38M
Interest Income
3.52M 265K
Pretax Income
-68.6M -29.44M
Net Income
-68.6M -29.44M
Selling & General & Admin
10.94M 5.5M
Research & Development
61.18M 33.88M
Other Expenses
n/a n/a
Operating Expenses
72.12M 39.38M
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
72.12M 39.38M
Income Tax Expense
n/a -265K
Shares Outstanding (Basic)
39.22M 40.31M
Shares Outstanding (Diluted)
39.22M 40.31M
EPS (Basic)
-1.75 -0.73
EPS (Diluted)
-1.75 -0.73
EBITDA
-70.59M -38.92M
EBIT
-72.12M -39.38M
Depreciation & Amortization
1.53M 455K